Evogene (EVGN) Exchange Rate Effect (2013 - 2026)
Evogene (EVGN) posted Exchange Rate Effect of $2000.0 for Q1 2026, down 77.78% sequentially from $9000.0 in Q4 2025, and up 110.0% YoY from $952.38 in Q1 2025.
Evogene (EVGN) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Evogene has reported Exchange Rate Effect for 14 years, with the latest figure at $2000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 110.0% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (up 184.31% YoY) and the FY2025 annual result came in at $21000.0, up 142.86% from the prior year.
- Exchange Rate Effect fell to $2000.0 in Q1 2026 per EVGN's latest filing, from $9000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $180000.0 in Q4 2022 and troughed at -$1.9 million in Q2 2022.
- A 5-year average of -$139785.7 and a median of -$10000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect tumbled 448.79% in 2022, then jumped 228.57% in 2025.
- Over 5 years, Exchange Rate Effect stood at $180000.0 in 2022, then slumped by 45.0% to $99000.0 in 2023, then sank by 107.07% to -$7000.0 in 2024, then surged by 228.57% to $9000.0 in 2025, then tumbled by 77.78% to $2000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $2000.0, $9000.0, and -$13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 | 2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Dec 31, 2025 | 9,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Mar 31, 2025 | -20,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Sep 30, 2023 | -28,000.00 |
| Sep 30, 2023 | -28,000.00 |